Tricone Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Revenue 19.83%
(FY 2019)
- Profit 51.98%
(FY 2019)
- Ebitda 34.63%
(FY 2019)
- Net Worth -51.84%
(FY 2019)
- Total Assets 28.79%
(FY 2019)
About Tricone Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sultana Nasreen, Venkateswara Varalingappagari, Ameesha Abdul, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290TG2016PTC112574
- Company No.
112574
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 2016
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tricone Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sultana Nasreen  | Director | 21-Oct-2016 | Current |
| Venkateswara Varalingappagari | Director | 21-Oct-2016 | Current |
| Ameesha Abdul | Additional Director | 11-Mar-2022 | Current |
| Noorjahan Shaik | Additional Director | 11-Mar-2022 | Current |
Financial Performance of Tricone Pharma.
Tricone Pharma Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 19.83% increase. The company also saw a substantial improvement in profitability, with a 51.98% increase in profit. The company's net worth observed a substantial decline by a decrease of 51.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tricone Pharma?
In 2017, Tricone Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tricone Pharma?
Unlock and access historical data on people associated with Tricone Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tricone Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tricone Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
